New hope for chronic stomach pain: DA-9701 put to the test

NCT ID NCT07686679

Not yet recruiting Symptom relief Sponsor: Dong-A ST Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether DA-9701, a drug for stomach discomfort, works better than a placebo or another active drug in people with functional dyspepsia—a condition causing persistent stomach pain and bloating without a clear cause. About 300 adults aged 19 to 75 with moderate to severe symptoms will take the drug three times daily. The study measures changes in gastrointestinal symptom scores and quality of life over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DA-9701
What this could lead to: If successful, this could provide a new treatment option for people with functional dyspepsia, helping to reduce stomach pain and discomfort.
What could go wrong: This is a phase 4 trial, so the drug is already approved; however, it may not work better than existing treatments, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dyspepsia functional gastric disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FUNCTIONAL DYSPEPSIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.